1. Home
  2. GILT vs GNFT Comparison

GILT vs GNFT Comparison

Compare GILT & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GILT
  • GNFT
  • Stock Information
  • Founded
  • GILT 1987
  • GNFT 1999
  • Country
  • GILT Israel
  • GNFT France
  • Employees
  • GILT N/A
  • GNFT N/A
  • Industry
  • GILT Radio And Television Broadcasting And Communications Equipment
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GILT Technology
  • GNFT Health Care
  • Exchange
  • GILT Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • GILT 281.1M
  • GNFT 296.4M
  • IPO Year
  • GILT 1993
  • GNFT 2019
  • Fundamental
  • Price
  • GILT $5.48
  • GNFT $5.60
  • Analyst Decision
  • GILT Strong Buy
  • GNFT Strong Buy
  • Analyst Count
  • GILT 2
  • GNFT 1
  • Target Price
  • GILT $8.50
  • GNFT $13.00
  • AVG Volume (30 Days)
  • GILT 111.3K
  • GNFT 16.5K
  • Earning Date
  • GILT 11-13-2024
  • GNFT 09-19-2024
  • Dividend Yield
  • GILT N/A
  • GNFT N/A
  • EPS Growth
  • GILT 229.32
  • GNFT N/A
  • EPS
  • GILT 0.35
  • GNFT 0.47
  • Revenue
  • GILT $292,248,000.00
  • GNFT $86,225,222.00
  • Revenue This Year
  • GILT $26.84
  • GNFT $155.44
  • Revenue Next Year
  • GILT $22.06
  • GNFT N/A
  • P/E Ratio
  • GILT $15.20
  • GNFT $12.24
  • Revenue Growth
  • GILT 12.61
  • GNFT 175.45
  • 52 Week Low
  • GILT $4.04
  • GNFT $3.08
  • 52 Week High
  • GILT $6.80
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • GILT 74.65
  • GNFT 49.77
  • Support Level
  • GILT $5.06
  • GNFT $5.51
  • Resistance Level
  • GILT $5.33
  • GNFT $6.03
  • Average True Range (ATR)
  • GILT 0.11
  • GNFT 0.21
  • MACD
  • GILT 0.04
  • GNFT -0.06
  • Stochastic Oscillator
  • GILT 97.01
  • GNFT 13.21

About GILT Gilat Satellite Networks Ltd.

Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs) and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: